Filing Details
- Accession Number:
- 0001181431-11-012654
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-02-24 09:10:18
- Reporting Period:
- 2011-02-22
- Filing Date:
- 2011-02-24
- Accepted Time:
- 2011-02-24 09:10:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 820096 | Perrigo Co | PRGO | Pharmaceutical Preparations (2834) | 382799573 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1321178 | Moshe Arkin | C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-02-22 | 43,626 | $74.41 | 6,277,298 | No | 4 | S | Indirect | By Nichsei Arkin Ltd. |
| Common Stock | Disposition | 2011-02-22 | 12,500 | $75.46 | 6,265,098 | No | 4 | S | Indirect | By Nichsei Arkin Ltd. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Nichsei Arkin Ltd. |
| No | 4 | S | Indirect | By Nichsei Arkin Ltd. |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,130 | Direct |
Footnotes
- The price in column 4 is a weighted average. The prices actually received ranged from $74.25 to $75.25. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range
- The price in column 4 is a weighted average. The prices actually received ranged from $75.29 to $75.80. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range
Billionaire Hedge Funds
